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Abstract  
In recent years, it is evidenced that the individuals newly infected HIV are 
transmitting the virus prior to knowing their HIV status. Identifying individuals that 
are early in infection with HIV antibody negative (window period) remains 
problematic. In the newly infected individuals, HIV antigen p24 is usually present in 
their serum or plasma 7-10 days before the HIV antibody. After antibody production 
initiates, the p24 antigen is bound into immune complexes. That means the detectable 
p24 antigens in serum/plasma are short-lived, and their amount is in the pg/ml range. 
Thus, a rapid quantitative bio-detection system with high-sensitivity is required to 
achieve early disease diagnosis. Magnetoresistive (MR) biosensor with ultra-high 
sensitivity possesses great potential in this area. In this study, a p24 detection assay 
using MgO-based magnetic tunnel junction (MTJ) sensor and 20-nm magnetic 




The early disease diagnosis requires the detection and quantification of disease 
biomarkers in serum, urine, or other bloody fluids. Benefit from the recent 
advancement of nanotechnology and thin-film technology, the magnetic immunoassay 
(MIA) utilizing magnetic nanoparticles and magnetoresistive sensor have attracted 
increasing attention in the biomedical area, due to its high sensitivity, low power 
consumption, low cost, and feasibility to be miniaturized.  
Magnetic tunnel junction (MTJ) sensors, one advanced kind of MR sensor, are 
recognized as an ideal sensor element for the biodetection due to their low cost, high 
sensitivity, and lab-on-chip compatibility. Compared with GMR sensors, MTJ sensors 
offer even higher MR ratio (such as, 604% at room temperature) and therefore 
potentially higher sensitivity at low magnetic field (especially for the magnetic field 
<1 Oe). [1, 2] Besides the magnetic field detector, the magnetic iron oxide 
nanoparticles (IONPs) have been a popular choice as bio-labels due to their physical 
and chemical stability, low toxicity, environmentally safe, and inexpensive to produce. 
The biodetection configuration utilizing IONPs and MTJ sensors has successfully 
been applied for bimolecular recognition and DNA detection in previous studies. [3-5] 
In this work, we demonstrate feasibility of magnetic biodetection for p24 antigens by 
using carboxyl-group functionalized magnetic IONPs with MTJs array sensors. 
p24 antigens are used here as biotarget is due to the fact that p24 antigen is the 
biomarker of HIV disease. Acquired immunodeficiency syndrome (AIDS) is the 
end-stage disease caused by human immunodeficiency virus (HIV) infection.[6] Early 
diagnosis of HIV and thus early treatment of patients has been confirmed to bring 
dramatic survival benefits, while unfortunately the early detection of HIV remains 
problematic. In recent years, it is evidenced that the individuals newly infected with 
HIV have transmitted the virus prior to knowing their HIV status. In the newly 
infected individuals, HIV antigen p24 is usually present in their serum or plasma 7-10 
days before the HIV antibody. The detectable amount of p24 antigens in 
serum/plasma is in the pg/ml range [1].Thus, the development of a rapid quantitative 
bio-detection system with high-sensitivity to detect the p24 antigen will greatly 
benefit the early diagnosis of HIV.  
 
1.1. Experimental part 
For the magnetic detection of p24, both of the IONPs and MTJ sensors need to be 
surface biologically functionalized. The magnetic iron oxide nanoparticles (Fe3O4, 
purchased from Ocean Nanotech) with carboxyl groups were used for the 
immobilization of the detecting antibodies via covalent bonding. [7]  Anti-p24 
antibodies were purchased from Abcam. The iron oxide nanoparticles (IONPs) were 
characterized under TEM observation and their magnetic property measurement was 
carried out at room temperature by using a vibrating sample magnetometer 
(Lakeshore, VSM 7400). The magnetization was measured over a range of applied 
field from around -10,000 to 10,000 Oe. 
 
1.1.1. Preparation of biofunctionalized magnetic IONPs 
The IONPs with carboxyl groups was conjugated with antibodies via 
1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDC)/ 
N-hydroxysuccinimide (NHS) coupling chemistry [8, 9], and Fig. 1 shows the 
chemical principle. Then the nanoparticles are incubated with detecting antibody and 
resuspended in storage buffer (PBS, phosphate buffered saline). The detailed 
procedure to carry out the biofunctionalization of IONPs with detecting antibodies is 
illustrated in Fig. 2. Briefly, the carboxyl groups-coated magnetic nanoparticles are 
activated by adding EDC and NHS. Then the nanoparticles are incubated with 
anti-p24 antibody and resuspended in storage buffer (PBS, phosphate buffered saline). 
Through this procedure, biofunctionalized IONPs were prepared with a concentration 
of 1.00 mg/ml, which can be stored for a few of months. All the buffers used here 
were purchased from Ocean Nanotech as a kit. 
 
 
Figure 1 Schematic principle of magnetic nanoparticles functionalization with 
detecting antibodies: (a) introduction of carboxyl groups-coated magnetic iron oxide 
nanoparticles (IONPs), (b) activation of a carboxylate moiety on the surface of IONP, 
(c) incubation with detecting antibody 
  
Figure 2 Schematic illustration of the preparation of detecting antibody conjugated 
magnetic iron oxide nanoparticles (IONPs).  
 
1.1.2. Preparation of surface-biofunctionalized MR sensor 
MR sensor is utilized in this platform to detect the magnetic signal of magnetic 
biolabels, including single MTJ sensor and MTJs array sensor (both purchased from 
Micro Magnetics), of which the surfaces were immobilized with capturing antibodies 
through a similar procedure. MTJs array sensor was bio-functionalized with anti-p24 
antibodies. A thickness of 200-nm gold layer was deposited on the top of MTJ sensing 
area, serving as bioactive area. The characterizations of single MTJ sensor and MTJs 
array sensor were carried out respectively through four-point probe measurement and 
two-point probe measurement, as discussed in Chapter 2.4.1. The detecting antibodies 
were immobilized on the MTJ sensing area through the procedures as shown in Fig. 3. 
The key point here is adding blocking solution (5% Skim Milk in PBS with 0.05% 
TWEEN 20) after the incubation of MTJ sensor with antibody solution droplet. We 
perform this blocking step to reduce undesirable non-specific binding of protein 
molecules on the MTJ sensor sensing area surface which might induce false results. 
[10] After the immobilization of antibodies, MTJ sensor surface was washed with 
PBST (phosphate-buffered saline with 0.05% TWEEN-20), and the capturing 
antibodies bio-functionalized MTJ sensor was prepared. 
 
 
Figure 3 Schematic illustration of the preparation of capturing antibodies 
biofunctionalized MTJ sensor. (a) One droplet of antibody solution was introduced 
onto the sensor sensing area surface. (b) Capturing antibodies were passively attached 
to the surface of MTJ sensor by incubation in buffer. (c) Blocking buffer was added to 
eliminate non-specific binding effect and block the remaining active area (blocking 
areas are represented by red color). (d) Biofunctionalized MTJ sensor was achieved. 
 
1.1.3. Magnetic immunoassay to detect biomarkers 
After the biofunctionalization of the IONPs with detecting antibodies and the MTJ 
sensor with capturing antibodies on its sensing area, the detection of target antigen 
biomolecules was carried out through a sandwich immunoassay configuration as 
illustrated in Fig. 4. Briefly speaking, the capturing antibodies functionalized MTJ 
sensor sensing area was initially covered with a solution containing target antigen 
biomolecules. Then the sensor surface was washed with PBST after the full binding of 
antigens with capturing antibodies immobilized onto the MTJ sensor surface. 
Subsequently, the detecting antibodies functionalized IONPs were introduced, and 
bound to the target antigens at the different epitopes from the capturing antibodies. 
After removing the excess IONPs by flushing the sensor surface with PBST, a 
hard-axis field of 60 Oe was applied for polarizing and magnetizing the IONP. The 
stray magnetic field of IONPs was detected by MTJ sensor, and the signal acquisition 
was performed on the single MTJ sensor through four-point probe measurement, and 
performed on the MTJs array sensor through two-point probe measurement.  
 
 
Figure 4 Schematic illustration of magnetic sandwich immunoassay based on MTJ 
sensor and magnetic iron oxide nanoparticles (IONPs). This system exploits the 
capturing antibodies functionalized MTJ sensor to capture biomarkers (antigens). The 
IONPs was labeled with detecting antibody. The target antigens were conjugated with 
both the capturing and detecting antibodies at different epitopes. 
 
1.2. Results 
The IONPs with carboxyl groups displayed a spherical morphology with size of 20 
nm and exhibited superparamagnetic behavior with a saturation magnetization (Ms) of 
50 emu/g.  
 
Detection of p24 antigens  
The MR array sensor consists of 76 junctions, and every junction stack was prepared 
through similar procedure as the single MTJ stack described previously. The MTJs 
array sensor was schematically drawn in Fig. 5a. Since the array sensor only contains 
two wire-bond pads, its MR transfer curve characterization was carried out through 
the traditional two-point probe measurement. The MTJs array sensor was placed on 
sample stage, shielded in a mu-metal shielding box to avoid the disturbances of 
ambient magnetic field. Two pairs of Helmholtz coils were utilized here. One pair of 
the coils provided a changeable magnetic field from -100 Oe to 100 Oe along the 
easy-axis and the other pair provided a 10-Oe hard-axis magnetic field on the MTJs 
array sensor, respectively. Fig. 5b shows the MR transfer curves of MTJs array sensor, 
with a sensitivity of 1.39%/Oe.  
 
 
Figure 5 (a) Schematic drawing of MTJs array sensor, consisting of 76 tunneling 
junctions indicated by ellipses. (b) MR loop of MTJs array sensor with 10 Oe of 
hard-axis bias field along the hard-axis. [11]  
 
The detection of target p24 biomolecules with concentrations of 0.001 mg/ml was 
realized through two-point probe measuring configuration with MTJs array sensor and 
biofunctionalized IONPs. A 10-Oe magnetic field was applied along the hard-axis of 
sensor to reduce the sensor hysteresis. The MR transfer curves of MTJs array sensor 
were measured before and after the binding of biofunctionalized IONPs though the 
conjugation with p24 on the MTJs array sensing area surface. The resistance 
variations ΔR of the sensor against easy-axis field changed is shown in Fig. 6a. A 
reference measurement was carried out where no IONPs were introduced. The 
maximum resistance deviations appear at approximately 50 Oe, with the maximum 
value of 1190 Ω, demonstrating the detection of p24 with concentration of 0.001 
mg/ml. Unfortunately, it was inconvenient to reuse the same MTJs array sensor after 
cleaned by piranha solution as what we did to the single MTJ sensor. The main reason 
is due to the difference of resistance measurement methods, where single MTJ sensor 
was measured through four-point probe way but MTJs array sensor was measured 
through two-point probe way. As discussed in Chapter 2, the resistance measured with 
two-point probe method includes the resistance of MR sensor as well as the lead 
resistance and contact resistance, where the four-point probe method can make more 
accurate resistance measurement of MR sensor. Thus, here we demonstrated the 
feasibility of sensitive detection of 0.001 mg/ml p24 antigens using carboxyl-group 
functionalized IONPs with MTJs array sensor, where more efforts are still needed to 
obtain the relation curve of p24 concentration versus ΔR of MTJs array sensor.  
 
 
Figure 6 Diagram of the MTJ sensor resistance variation ΔR after binding with the 
target p24 antigens with a concentration of 0.001 mg/ml. The maximum resistance 
deviations appear at approximately 50 Oe, with the maximum value of 1190 Ω. 
 
Conclusion and outlook  
In summary, we have demonstrated the feasibility of HIV disease immunoassay with 
carboxyl-group functionalized IONPs and MTJ sensors by a sandwich-assay 
configuration. The MTJ sensors and IONPs were biologically treated with capturing 
antibodies and detecting antibodies before the magnetic biodetection experiments. 
MTJs array sensor with a sensing area of 890 ×890 µm2 (almost the whole surface 
area of sensor) possessing a sensitivity of 1.39%/Oe was used to detect p24 antigens, 
HIV disease biomarker. It was demonstrated that the p24 antigens could be detected at 
a concentration as low as 0.001 mg/ml. However, due to the interference of contact 
resistance on the measured resistance through two-point probe measurement, it is 
inconvenient for the MTJs array sensor to be reused in new experiment after piranha 
wash because of varying contact resistance might be caused in every new experiment. 
Thus, the sensitive detection of 0.001 mg/ml p24 antigens was demonstrated here 
using carboxyl-group functionalized IONPs with MTJs array sensor, where more 
efforts are still needed to obtain the relation curve of p24 concentration versus ΔR of 
MTJs array sensor. 
Furthermore, the magnetic biodetection of p24 antigens for health care was firstly 
realized here based on the configuration of MTJ sensors and carboxyl-group 
functionalized IONPs, where the detection sensitivity still have plenty room for 
improvement. It has been demonstrated by a research group in Germany that 
biodetection based on GMR sensor was superior to fluorescent biodetection.[12] 
Besides, it is known that MTJ sensor offer higher MR ratio and therefore higher 
sensitivity at low magnetic field than GMR sensor, and a single MTJ sensor has the 
ability to detect single magnetic nanoparticle.[2] Thus, we can expect that the 
detection sensitivity of our configuration based on MTJ sensor has potential to be 
improved to be less than 1 ng/ml for p24 antigens after the further optimization. 
In addition, the multiplex sensing and miniaturization are also a very worthwhile 
future work for our magnetic biodetection configuration. The multiplex sensing of 
different bioanalytes can be realized by pre-mobilizing different capturing molecules 
on different working areas on a MR sensor array. [13] And the compatibility of MR 
sensor with the standard CMOS fabrication technology enables great promise for our 
magnetic biodetection platform to be miniaturized to for lab-on-chip application for 
point-of-care with high-sensitivity and low-cost. [14] 
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